1. Alasia DD, Emem-Chioma PC, Wokoma FS. Association of lead exposure, serum uric acid and parameters of renal function in Nigerian lead-exposed workers. Int J Occup Environ Med. 2010; 1:182–190. PMID:
23022807.
2. Pant SS, Moser HW, Krane SM. Hyperuricemia in Down's syndrome. J Clin Endocrinol Metab. 1968; 28:472–478. PMID:
4230664.
Article
3. Giordano N, Santacroce C, Mattii G, Geraci S, Amendola A, Gennari C. Hyperuricemia and gout in thyroid endocrine disorders. Clin Exp Rheumatol. 2001; 19:661–665. PMID:
11791637.
4. Miguel AL, Yuri YS, Ahsan Ejaz A, Magdalena M, MyPhuong L, Jacek M, et al. Uric acid and metabolic syndrome: what is the relationship? Curr Rheumatol Rev. 2011; 7:162–169.
5. Mankovsky B, Kurashvili R, Sadikot S. Is serum uric acid a risk factor for atherosclerotic cardiovascular disease? A review of the clinical evidence. Part 1. Diabetes Metab Syndr. 2010; 4:176–184.
6. Parvin S, Hoque MM, Sultana N, Chowdhury NS, Chowdhury SS, Akhter S, et al. Study of serum uric acid in cerebrovascular disease. J Dhaka Med Coll. 2009; 18:15–19.
Article
7. Wilson DM, Goldstein NP. Renal urate excretion in patients with Wilson's disease. Kidney Int. 1973; 4:331–336. PMID:
4762580.
Article
8. Passeron A, Blanchard A, Capron L. Hypo-uricemia in the syndrome of inappropriate secretion of antidiuretic hormone: a prospective study. Rev Med Interne. 2010; 31:665–669. (in French). PMID:
20598782.
9. Duncan PH, Gochman N, Cooper T, Smith E, Bayse D. A candidate reference method for uric acid in serum. I. Optimization and evaluation. Clin Chem. 1982; 28:284–290. PMID:
7055949.
Article
10. Siekmann L. Determination of uric acid in human serum by isotope dilution-mass spectrometry. Definitive methods in clinical chemistry, III. J Clin Chem Clin Biochem. 1985; 23:129–135. PMID:
3889217.
Article
11. Ellerbe P, Cohen A, Welch MJ, White E 5th. Determination of serum uric acid by isotope dilution mass spectrometry as a new candidate definitive method. Anal Chem. 1990; 62:2173–2177. PMID:
2268051.
Article
12. Stöckl D, Reinauer H. Candidate reference methods for determining target values for cholesterol, creatinine, uric acid, and glucose in external quality assessment and internal accuracy control. I. Method setup. Clin Chem. 1993; 39:993–1000. PMID:
8504568.
Article
13. Japan Society of Clinical Chemistry. Recommended method for determination of uric acid in serum by HPLC. Jpn J Clin Chem. 1993; 22:300–307. (in Japanese).
14. Dai X, Fang X, Zhang C, Xu R, Xu B. Determination of serum uric acid using high-performance liquid chromatography (HPLC)/isotope dilution mass spectrometry (ID-MS) as a candidate reference method. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 857:287–295.
Article
16. Duncan P, Gochman N, Bayse D, Burnett R, Carey N, Carter R, et al. A candidate reference method for uric acid in serum. II. Interlaboratory testing. Clin Chem. 1982; 28:291–293. PMID:
7055950.
Article
17. Kock R, Delvoux B, Tillmanns U, Greiling H. A candidate reference method for the determination of uric acid in serum based on high performance liquid chromatography, compared with an isotope dilution-gas chromatography-mass spectrometer method. J Clin Chem Clin Biochem. 1989; 27:157–162. PMID:
2651552.
Article
18. Sakuma R, Nishina T, Kitamura M. Deproteinizing methods evaluated for determination of uric acid in serum by reversed-phase liquid chromatography with ultraviolet detection. Clin Chem. 1987; 33:1427–1430. PMID:
3608161.
Article
19. Yasushi C, Kazuko K, Naomi N. Comparative study on a high performance liquid chromatographic method and an enzymatic (uricase-UV) method for determination of serum uric acid. Bull Ginkyo Coll Med Sci. 1993; 17:21–28. (in Japanese).
http://ci.nii.ac.jp/naid/110004299689.
20. Clinical and Laboratory Standards Institute. EP5-A2. Evaluation of precision performance of quantitative measurement methods. approved guideline-second edition. Wayne, PA: CLSI;2004.
21. Clinical and Laboratory Standards Institute. EP9-A2. Method comparison and bias estimation using patient samples. approved guideline-second edition. Wayne, PA: CLSI;2002.
22. International Organization for Standardization. ISO Guide 35: Reference materials-General and statistical principles for certification. 3rd ed. Geneva: ISO;2006.
23. Clinical and Laboratory Standards Institute. EP14-A2. Evaluation of matrix effects. approved guideline-second edition. Wayne, PA: CLSI;2005.
24. Fraser CG, Hyltoft Petersen P, Libeer JC, Ricos C. Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem. 1997; 34:8–12. PMID:
9022883.
Article
25. Ricós C, Alvarez V, Cava F, García-Lario JV, Hernández A, Jiménez CV, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest. 1999; 59:491–500. PMID:
10667686.
28. Miller WG, Myers GL, Ashwood ER, Killeen AA, Wang E, Ehlers GW, et al. State of the art in trueness and interlaboratory harmonization for 10 analytes in general clinical chemistry. Arch Pathol Lab Med. 2008; 132:838–846. PMID:
18466033.
Article